CertiK Unveils SkyInsightsTM: A Game-Changer in Crypto Compliance and Risk Management 13-09-2023, 12:36

Io Therapeutics, Inc., announces presentation of data from studies of its RAR gamma agonist compound IRX5010 in treatment of a mouse model of triple negative breast cancer, demonstrating combination treatment effects with an anti-PDL-1 monoclonal antibody 12-12-2024, 04:35

Hadley & Lyden Joins World Insurance Associates 15-03-2023, 20:12